Hims & Hers Health, Inc. (HIMS) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
HIMS representa a Hims & Hers Health, Inc., una empresa del sector Healthcare con un precio de $22.02 (capitalización de mercado 5B). La acción obtiene una puntuación de 56/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 9 feb 2026Hims & Hers Health, Inc. (HIMS) Resumen de Asistencia Médica y Tuberías
Hims & Hers Health is revolutionizing healthcare access with its multi-specialty telehealth platform, offering personalized wellness solutions and prescription medications directly to consumers. With a strong focus on convenience and affordability, HIMS is poised to capitalize on the growing demand for digital health services and expand its market share.
Tesis de Inversión
Hims & Hers Health presents a notable research candidate due to its strong growth trajectory and disruptive business model. The company's direct-to-consumer telehealth platform is capitalizing on the increasing demand for convenient and affordable healthcare solutions. With a gross margin of 75.0% and a focus on recurring revenue through subscription-based prescription services, Hims & Hers is demonstrating strong financial performance. The company's ability to expand its product offerings and attract new customers through targeted marketing campaigns positions it for continued growth. Furthermore, the increasing acceptance of telehealth and the company's strategic partnerships with wholesale partners create significant opportunities for market expansion. The company's P/E ratio is 38.95, reflecting investor confidence in its future earnings potential. As Hims & Hers continues to innovate and scale its platform, it is poised to deliver significant value to shareholders.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $5.05B reflects strong investor confidence in the company's growth potential.
- Gross Margin of 75.0% indicates efficient operations and strong pricing power.
- P/E ratio of 38.95 suggests investors are willing to pay a premium for HIMS's earnings, anticipating future growth.
- The company operates a multi-specialty telehealth platform, offering a wide range of services and products.
- Hims & Hers connects consumers directly to licensed healthcare professionals, providing convenient and accessible care.
Competidores y Pares
Fortalezas
- Strong brand recognition and reputation.
- Proprietary telehealth platform.
- Subscription-based revenue model.
- Direct-to-consumer approach.
Debilidades
- Reliance on marketing spend for customer acquisition.
- Limited physical presence.
- Regulatory risks associated with telehealth and prescription medications.
- Competition from established healthcare providers and other telehealth companies.
Catalizadores
- Ongoing: Continued expansion of product offerings and services.
- Ongoing: Increasing adoption of telehealth among consumers.
- Upcoming: Potential partnerships with major healthcare providers.
- Ongoing: Strategic marketing initiatives to drive customer acquisition.
Riesgos
- Potential: Changes in regulations governing telehealth and online prescriptions.
- Potential: Increased competition from other telehealth providers.
- Ongoing: Reliance on third-party suppliers for products and medications.
- Potential: Data security breaches and privacy concerns.
- Ongoing: High marketing expenses impacting profitability.
Oportunidades de crecimiento
- Expansion into New Markets: Hims & Hers has the opportunity to expand its services into new geographic markets, both domestically and internationally. By leveraging its telehealth platform and marketing expertise, the company can reach a wider customer base and drive revenue growth. The global telehealth market is projected to reach $55.6 billion by 2027, representing a significant opportunity for Hims & Hers to expand its reach and capture market share. Timeline: Ongoing.
- Introduction of New Product Lines: Hims & Hers can further expand its product offerings to address a wider range of health and wellness needs. By introducing new product lines, such as chronic disease management programs or specialized skincare solutions, the company can attract new customers and increase revenue per user. The market for personalized health and wellness products is growing rapidly, driven by increasing consumer awareness and demand for customized solutions. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Hims & Hers can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. By partnering with established healthcare providers or acquiring complementary telehealth companies, Hims & Hers can accelerate its growth and enhance its competitive position. The market for telehealth acquisitions is active, with companies seeking to consolidate their market share and expand their service offerings. Timeline: Ongoing.
- Enhancement of Technology Platform: Hims & Hers can continue to invest in its technology platform to improve the user experience and enhance its service offerings. By incorporating new features, such as AI-powered personalized recommendations or virtual reality-based therapy programs, the company can differentiate itself from competitors and attract new customers. The market for telehealth technology is constantly evolving, with new innovations emerging regularly. Timeline: Ongoing.
- Increased Focus on Mental Health Services: Hims & Hers can capitalize on the growing demand for mental health services by expanding its offerings in this area. By providing access to licensed therapists and offering personalized mental health programs, the company can address a critical unmet need and drive revenue growth. The market for mental health services is experiencing significant growth, driven by increasing awareness and acceptance of mental health issues. Timeline: Ongoing.
Oportunidades
- Expansion into new markets and product lines.
- Strategic partnerships and acquisitions.
- Increased focus on mental health services.
- Enhancement of technology platform.
Amenazas
- Changes in telehealth regulations.
- Increased competition from new entrants.
- Data security and privacy breaches.
- Negative publicity or product recalls.
Ventajas competitivas
- Brand Recognition: Strong brand recognition and reputation in the direct-to-consumer telehealth market.
- Proprietary Technology Platform: User-friendly and scalable telehealth platform that connects consumers with healthcare professionals.
- Subscription-Based Revenue Model: Recurring revenue stream from prescription medications and ongoing care.
- Data and Personalization: Ability to leverage data to personalize treatment plans and product recommendations.
Acerca de HIMS
Founded in 2017, Hims & Hers Health, Inc. emerged with a vision to transform the healthcare landscape by providing accessible and convenient solutions for everyday health needs. Recognizing the challenges individuals face in accessing traditional healthcare, the company pioneered a direct-to-consumer telehealth platform that connects users with licensed healthcare professionals. Initially focused on addressing stigmatized conditions like hair loss and erectile dysfunction, Hims & Hers has expanded its offerings to encompass a comprehensive range of health and wellness categories, including skincare, mental health, and primary care. The company's evolution has been marked by a commitment to innovation and customer-centricity, leveraging technology to deliver personalized and affordable healthcare solutions. Today, Hims & Hers operates a robust platform that offers prescription medication, over-the-counter products, and ongoing care from healthcare providers. With a strong emphasis on discretion and convenience, the company has cultivated a loyal customer base and established itself as a leader in the rapidly growing telehealth market. Hims & Hers continues to expand its product offerings and services, solidifying its position as a comprehensive digital health destination. The company's headquarters are located in San Francisco, California, and it serves customers across the United States.
Qué hacen
- Connect consumers with licensed healthcare professionals through a telehealth platform.
- Offer prescription medication for various health conditions.
- Provide over-the-counter drug and device products.
- Offer cosmetics and supplement products.
- Focus on wellness, sexual health, skincare, and hair care.
- Provide medical consultation services.
- Offer health and wellness products through wholesale partners.
Modelo de Negocio
- Direct-to-consumer sales of prescription and non-prescription products through their website and mobile app.
- Subscription-based recurring revenue for prescription medications and ongoing care.
- Revenue from medical consultation services provided by licensed healthcare professionals.
- Wholesale partnerships to distribute health and wellness products through other retailers.
Contexto de la Industria
The telehealth industry is experiencing rapid growth, driven by increasing demand for convenient and affordable healthcare solutions. The market is characterized by intense competition, with companies vying for market share by offering innovative services and products. Hims & Hers Health is well-positioned to capitalize on this trend, leveraging its direct-to-consumer platform and comprehensive range of health and wellness offerings. The company faces competition from established healthcare providers and other telehealth companies, but its focus on personalized care and discreet service provides a competitive edge. The telehealth market is projected to continue its growth trajectory, creating significant opportunities for Hims & Hers to expand its market share and solidify its position as a leader in the industry.
Clientes Clave
- Individuals seeking convenient and affordable access to healthcare.
- Consumers looking for solutions to address specific health conditions, such as hair loss, erectile dysfunction, and skincare concerns.
- People seeking personalized health and wellness products and services.
- Customers who value discretion and privacy in their healthcare experience.
Finanzas
Gráfico e información
Precio de la acción de Hims & Hers Health, Inc. (HIMS): $22.02 (-2.14, -8.86%)
Últimas noticias
-
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank?
benzinga · 2 abr 2026
-
Tempus (TEM) Down 12.9% Since Last Earnings Report: Can It Rebound?
Zacks · 26 mar 2026
-
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?
Yahoo! Finance: HIMS News · 23 mar 2026
-
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
benzinga · 23 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para HIMS.
Objetivos de Precios
Objetivo de consenso: $20.19
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de HIMS en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Competidores y Pares
Últimas Noticias
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank?
Tempus (TEM) Down 12.9% Since Last Earnings Report: Can It Rebound?
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
Último análisis de Hims & Hers Health, Inc.
Hims & Hers Surges 40.79% on Weight-Loss Drug Deal, AZI Skyrockets 146.40%
3 min de lecturaCyclical Value Stocks in Focus as ODFL Drops 7.93%, EONR Jumps 9.84%
4 min de lecturaPapa John's Surges 3.70% Amid Resurgence of 'Pentagon Pizza' Theory
2 min de lecturaPayPal Gains 5.76% Amid Acquisition Rumors, Novo Nordisk Plunges 16.43%
3 min de lecturaTech Sector Weakness Drags on Market, QQQ Down 1.44%
3 min de lecturaAcciones de Hims & Hers Health, Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar HIMS?
Hims & Hers Health, Inc. (HIMS) actualmente tiene una puntuación IA de 56/100, indicando puntuación moderada. La acción cotiza a un P/E de 38.9x, por encima del promedio del S&P 500 (~20-25x), sugiriendo altas expectativas de crecimiento. Los analistas apuntan a $20.19 (-8% desde $22.02). Fortaleza clave: Strong brand recognition and reputation.. Riesgo principal a monitorear: Potential: Changes in regulations governing telehealth and online prescriptions.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de HIMS?
HIMS actualmente puntúa 56/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de HIMS?
Los precios de HIMS se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre HIMS?
Los analistas han establecido un precio objetivo de consenso de $20.19 para HIMS, representando un potencial bajista del 8% desde el precio actual de $22.02. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en HIMS?
Las categorías de riesgo para HIMS incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in regulations governing telehealth and online prescriptions.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de HIMS?
Hims & Hers Health, Inc. (HIMS) tiene una relación P/E de 38.9, que está por encima del promedio del mercado, lo que puede indicar altas expectativas de crecimiento. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.
¿Está HIMS sobrevalorada o infravalorada?
Determinar si Hims & Hers Health, Inc. (HIMS) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 38.9. Objetivo de analistas $20.19 (-8% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de HIMS?
Hims & Hers Health, Inc. (HIMS) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data and may be subject to change.
- Investment decisions should be made based on individual risk tolerance and financial circumstances.